Showing results (171-180 of 202) with videos related to
Sort By:
Pageof 21
Journal of Thrombosis and Haemostasis : JTH|November 11, 2017
Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithmN Riva, G Camporese, M Iotti, et al.Journal of Thrombosis and Haemostasis : JTH|April 8, 2015
Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort studyN Riva, W Ageno, D Poli, et al.The New England Journal of Medicine|July 21, 2001
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial InvestigatorsG Agnelli, P Prandoni, M G Santamaria, et al.Clinical Cardiology|May 22, 1998
Management strategies for a better outcome in unstable coronary artery diseaseR W Campbell, L Wallentin, F W Verheugt, et al.Thrombosis and Haemostasis|April 1, 2000
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimerP S Wells, D R Anderson, M Rodger, et al.Lancet (London, England)|September 12, 2001
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trialP M Bath, E Lindenstrom, G Boysen, et al.Journal of the American College of Cardiology|September 15, 2000
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary EventsS G Goodman, M Cohen, F Bigonzi, et al.Circulation|October 12, 1999
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trialE M Antman, C H McCabe, E P Gurfinkel, et al.Thrombosis Research|October 1, 2015
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO studyF Pomero, M N D Di Minno, E Tamburini Premunian, et al.Journal of Thrombosis and Haemostasis : JTH|April 2, 2015
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN StudyC W Francis, C M Kessler, S Z Goldhaber, et al.Pageof 21